MICARDIS
LOE ApproachingNDAORALTABLET
Approved
Nov 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
MICARDIS by Boehringer Ingelheim is properties: a thiazide diuretic, hydrochlorothiazide, and an angiotensin ii receptor blocker (arb), telmisartan. Approved for hypertension, to lower blood pressure, alone and 1 more indications. First approved in 1998.
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MICARDIS is an oral fixed-dose combination antihypertensive containing telmisartan (an angiotensin II receptor blocker) and hydrochlorothiazide (a thiazide diuretic). It works by blocking angiotensin II-mediated vasoconstriction and reducing plasma volume to lower blood pressure. The drug is indicated as monotherapy or in combination with other antihypertensive agents for hypertension management.
$0.002BPart D
LOE ApproachingDeclining
Mature brand with minimal Part D claims and approaching loss of exclusivity signals a contracting commercial operation and potential team consolidation.
Mechanism of Action
properties: a thiazide diuretic, hydrochlorothiazide, and an angiotensin II receptor blocker (ARB), telmisartan. Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the…
Indications (4)
Worked on MICARDIS at Boehringer Ingelheim? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.